Possible link of Chronic arsenic toxicity with  Chronic Kidney Disease of unknown etiology in Sri Lanka by Jayasumana, M.A.C.S. et al.
Journal of Natural Sciences Research                                                                                                         www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.1, 2013 
 
64 
Possible link of Chronic arsenic toxicity with  
Chronic Kidney Disease of unknown etiology in Sri Lanka 
 
M.A.C.S.Jayasumana
1*
 P.A.Paranagama
2
, M.D. Amarasinghe
2
, K.M.R.C.Wijewardane
3
,
 
K.S.Dahanayake
4 
S.I.Fonseka
2
,K.D.L.M.P.Rajakaruna
5
,A.M.P.Mahamithawa
1
,U.D.Samarasinghe
6
,V.K.Senanayake
2
 
1. Department of Pharmacology, Faculty of Medicine, Rajarata University, Anuradhapura, Sri Lanka 
2. Faculty of Science, University of Kelaniya, Sri Lanka 
3. Government Hospital, Padavi Sri pura,Sri Lanka 
4. District General Hospital, Monaragala, Sri Lanka 
5. Base Hospital, Dambulla 
6. Base Hospital, Karawanella 
* E-mail of the corresponding author: jayasumanalk@yahoo.com 
Abstract 
In recent years a significant increase in number of patients of Chronic Kidney Disease of unknown etiology (CKDu) 
has been observed in some parts of Sri Lanka,
 
especially in the North Central Province. A case control study has been 
performed with the intention of determining the prevalence of clinical features of Chronic Arsenic Toxicity (CAT) 
among CKDu patients in Padavi Sripura divisional secretarial area in Trincomalee District, Sri Lanka. Clinical 
assessment were done in diagnosed CKDu patients (n=125) and non-CKDu persons (n=180) as the control group. 
Hair and urine samples collected from both CKDu patients and controls were analyzed for presence of arsenic using 
Atomic Absorption Spectrometry equipped with Hydride generator (HG-AAS).The results revealed that 68% of 
CKDu patients and 28% of the controls had urine arsenic levels above 21 µg/g creatinine, which is considered the 
point of threshold for manifestation of early renal changes that can be developed in to chronic kidney disease. 
Among the CKDu patients, 48% and 17.4% of the subjects in the control group have fulfilled the criteria to be 
diagnosed CAT, indicating the potential link between CAT and CKDu. Agrochemicals could be the possible source 
for this contamination of arsenic since no reported work is available to indicate the presence of arsenic in the 
bedrocks of Sri Lanka. 
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01.Introduction 
1.1 Chronic Kidney Disease of unknown etiology (CKDu) 
During the last two decades, noteworthy numbers of patients with Chronic Kidney Disease were reported from 
Rajarata area of Sri Lanka. Rajarata was one of the three administrative divisions of ancient Sri Lanka and it was the 
epicentre of Sinhala Buddhist civilization where two ancient capitals, Anuradhapura and Polonnaruwa are located. 
Geographically, Rajarata area encompasses the present day North Central Province and parts of adjacent Provinces in 
Sri Lanka.(Fig 01) 
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Fig. 01  Provinces of Sri Lanka, Geographical distribution of CKDu patients and study area 
Causality of CKDu appears to be different to that of other renal failures, which result from diabetes, high blood 
pressure, past snake bites or urinary tract infections. This disease therefore is named as Chronic Kidney Disease of 
unknown etiology (CKDu) based on recommendations of the National Research Programme for CKDu of the 
Ministry of Health in Sri Lanka.(Circular No 01-10/2009, Ministry of Health ,Sri Lanka.) This has been first 
identified in the 1990s, to be endemic to certain geographical areas of Sri Lanka including Medawachchiya, 
Padaviya, Kebithigollawa (North Central Province),Nikawewa, Giribawa, Nickaweratiya (North Western 
Province),Dehiattakandiya (Eastern Province) and Giradurukotte (Uva Province) (Jayasumana 2010).  
The CKDu is a slowly progressive disease. Patients are asymptomatic during most part of the disease course and 
there are no specific clinical features. The disease onset is in adolescence and the proportion of cases developing 
chronic renal failure increases with increasing age indicating the progressive nature of the disease. (Athuraliya et 
al.2009) Histopathological findings have shown tubular interstitial nephritis with or without nonspecific interstitial 
mononuclear cell infiltration associated with glomerular atrophy and glomerular loss. Disease is characterized by 
tubular proteinurea usually alpha-1 and beta-2 microglobulinuria, high urine NGal levels (>300ng/mg creatinine/dL) 
and the absence of edema.(Jayasumana 2012). 
The primary medico-legal drawback associated with the disease is that deceased patients are not subjected to 
medico-legal autopsies and the bodies are released giving the cause of death as chronic kidney disease of unknown 
etiology. This has caused an enormous loss of valuable autopsy evidences which are of utmost importance to reveal 
its etiology. 
In the past, several researchers have attempted to explain the etiology of CKDu. Herath et al. (2005) reported that 
high fluoride content in drinking water may be the cause of CKDu, nevertheless, they have not been able to explain 
the reasons for absence of CKDu in places where drinking water contains extremely high content of fluoride. 
Toxicity was hypothesized to be caused by aluminium fluoride formed by the reaction between fluoride in water with 
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aluminium in low-quality utensils that are in wide use in these areas. It has been reported that aluminium fluoride is a 
neurotoxic which cause Alzhiemier’s disease (Foncin et al.1986) and it is not observeed among CKDu patients. 
Although the usage of low quality aluminium untensils was discouraged by the govenrnment in CKDu endemic 
areas, the statistics of CKDu patients indicate that the rapid increase in number of CKDu patients in Rajarata. 
Bandara et al. (2008) reported that presence of high concentrations of cadmium in drinking water and food as a 
potential cause of CKDu. Chandrajith et al. (2010) have shown that no such high cadmium levels were detected in 
drinking water and food from the CKDu endemic areas. It is most unlikely therefore that fluoride and cadmium are 
the sole causative agents of CKDu. Later in 2010, it was reported that presence of toxins produced by cynobacteria in 
surface waters, particularly in the freshwater reservoirs was the reason for the disease, nevertheless results could not 
bring out a plausible explanation for prevalence of CKDu only among those who drink groundwater. As such, none 
of the previous work on the subject could adequately explain etiology of CKDu. 
Being an agrochemical (Chemical fertilizers and Pesticides) using male paddy farmer who drinks water with high 
hardness has been identified to be of highest risk for CKDu (Jayasumana 2012). Majority of people in north central, 
north western and eastern Sri Lanka are paddy farmers and they are heavily exposed to pesticides and fertilizers. 
Agrochemicals are freely and irrationally used and very little attention is given to hazardous effects on human health. 
Prevalence of diseases comparable to CKDu has been reported to occur among young male sugarcane farmers in El 
Salvador,Central America, resulting in substantial morbidity and mortality.(Orantes et al 2011). Symptoms are most 
consistent with tubulointerstitial disease. A similar scenario has also been reported from Upper Egypt where 
investigators have noted abnormal increase in CKD patients among male farmers who use pesticides (Kamel et 
al.2010). 
Arsenic is an infamous toxin which has caused major human health problems in several parts of the world and 
concern over such incidents has prompted investigations into the nephrotoxic effects of arsenic. Early studies have 
shown acute or sub acute arsenic poisoning can cause tubulointerstitial nephritis.(Prasad et al.1995) But no detail 
study is available to show the nephrotoxic effect of chronic arsenic poisoning and present study is the first study 
conducted on potential link of arsenic for prevalence of CKD. 
 
1.2 Arsenic  
Arsenic (As) is considered an extremely toxic element and a “non threshold carcinogen” found to occur in the 
environments around the globe. (Meharg 2010). Arsenic is a naturally occurring metalloid and it can exist in 
inorganic or organic forms. Since most of the organic or inorganic arsenic compounds are white or colorless, without 
a smell or taste, it is difficult to detect its presence in food, water and air. The inorganic forms of arsenic are more 
toxic than its more complex organic compound.  Toxicity of arsenic has been reported to be as Arsine > Arsenite > 
Arsenoxide >Arsenates >Arsenic. These toxic arsenic compounds, particularly, copper, lead, sodium, calcium and 
zinc arsenates were in use to control insect pests, weeds, molds, bacteria, and rodents. 
It has been well-established that arsenic compounds have detrimental effects on health of living beings. Incidents of 
arsenic contamination in groundwater have been reported from many countries (Henke 2009). Arsenic toxicity in 
drinking water and food remains a problem in many parts of the world. Among the various sources of arsenic in the 
environment, drinking water probably poses the greatest threat to human health, especially for arsenic concentrations 
that have been observed in ground water. (Bhattacharya et al. 2002) In water, arsenic is frequently found in inorganic 
species such as arsenite (AsO3
3-
) and arsenate (AsO4
3-
), referred to as As(III) and As(V), respectively, which have 
reported to cause harmful effects on humans, plants and animals (Henke 2009). Based on human health data, World 
Health Organization (WHO) has recommended a maximum permissible contaminant level for arsenic as 10μg/L for 
drinking water. (WHO guidelines for Drinking water quality,1996). Ill effects of chronic arsenic toxicity have drawn 
attention of scientists since early 1980s and extensive studies on the subject therefore have only been reported during 
the last two decades. 
Diagnosis of arsenic toxicity, especially from low doses of inorganic arsenic is very complicated as there are no 
distinct symptoms since people exposed to it respond differently, depending on the extent of exposure and the nature 
of the source. Arsenic can be inhaled, ingested or absorbed through skin. Arsenic which remains in body is stored in 
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the liver, kindney, brain, and other tissues and causes serious damage to them as it is able to bio-accumulate within 
living cells. Long term arsenic exposure, even at low levels, can result in a range of symptoms (Muzumder 2000). 
Contaminations of arsenic in drinking water, food, air or soil have not been studied in Sri Lanka comprehensively. 
There are no records available therefore on occurrence of arsenic in bedrocks, soil and water of Sri Lanka.  
Initial clue for the present study has immerged while the first author was engaged in his PhD research on etiology of 
CKDu. Abnormal spotty pigmentation observed in palms and soles of CKDu patients during clinical examinations of 
CKDu patients, that were subsequently confirmed by Medical officer of Padavi Sripura hospital was a basis for the 
hypothesis that chronic arsenic toxicity could be a cause of CKDu. Objectives of the present study therefore was to 
determine the prevalence of clinical features and analysis of urine and hair samples for arsenic levels, with the 
intention of assessing chronic arsenic toxicity (CAT) among CKDu patients in Padavi Sripura divisional secretarial 
area in Trincomalee District, Eastern Province of Sri Lanka. 
 
02. Study design, setting and methods 
2.1 Study area  
Paddy farming areas irrigated with water from Padaviya reservoir and associated agricultural settlements were 
included in the study area.  
2.2 Clinical assessments of CKDu patients 
A reconnaissance survey was conducted in the study villages by the medical doctors in this research team followed 
by a door-to-door survey to gather background information on CKDu patients. Then, the selected individuals 
diagnosed to suffer from CKDu were requested to attend medical camps organized at Government Hospital at 
Sripura and biological samples (hair and urine) were collected from them. 
Study was conducted during December 2010 to July 2011 with the concurrence of Ethics Committee of the Faculty 
of Medicine and Allied Sciences of Rajarata University of Sri Lanka. Written informed consent was obtained from 
all the individuals who have participated in the study.   
During the clinical observations of patients (n=125), signs and symptoms of chronic arsenic poisoning such as hyper-
pigmentation, keratosis in palms and soles, generalized body weakness, headache, burning eyes, anemia, nausea, 
mild to moderate hepatomegaly and spleenomegaly, epigastric pain and paresthesia were observed and recorded. 
Control group (n=180) were selected from those individuals from the study area who have not been diagnosed to 
have CKDu and some of them were selected randomly from family members of CKDu patients. 
2.3 Sample collection and preparation  
Urine samples were collected from selected CKDu patients from the study area into acid-washed (10% nitric acid) 
polypropylene bottles. Immediately after collection, the samples were stored in salt–ice mixture and brought to the 
laboratory where they were kept at 4
o
C until measurement of arsenic content.  
Hair (300–500 mg) samples were collected using a cleaned pair of scissors from the same individuals from whom 
urine samples were collected and kept in plastic bags. They were brought to the laboratory, washed with de-ionized 
water, followed by acetone for 10 minutes each and finally were dried in an oven at 50
o
C.  
2.4 Apparatus  
GBC 932 plus Atomic Absorption Spectrometer-AAS (Australia) equipped with a hydride generation system (GBC 
3000) and Graphite Furnace (GF 3000) with the background corrector was used to detect arsenic content in all the 
samples. Arsenic hollow cathode lamp was utilized to detect arsenic in the samples.  
2.5 Chemicals and reagents 
Reagents of analytical grade and deionized water (Bransstead E Pure, Model 4832-33) were used for the analyses. 
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Stock solution of arsenic trichloride (AsCl3) with concentration of 1000 mg/L in 1M HCl (VWR International LTD, 
England) was used for the standard solution preparation for atomic absorption spectrometer. Initially a standard 
solution of 10 mg/L was prepared from the stock solution (1000 mg/L) using a mixture solution of nitric acid (10%). 
Then, a standard solution of 1 mg/L was prepared, directly from the 10 mg/L standard, using the same mixture of 
solutions. Finally, solutions of 1µg/L, 5µg/L, 10 µg/L, 20µg/L,30µg/L and 100µg/L were prepared. Stock solutions 
were kept in polyethylene bottles and kept at 4 
o
C. Standard solutions were prepared daily for analyses. The 
calibration curves were established with the standard solutions and the square of correlation coefficient (R
2
) was in 
the range of 0.987 - 0.999 in most occasions while AAS was in use. 
2.6 Digestion of samples 
Digestion of samples was carried out with concentrated nitric acid (70% AR) (Sigma Aldrich Pvt. Ltd), concentrated 
sulfuric acid (98% AR) (Sigma Aldrich Pvt. Ltd), perchloric acid (70% AR) (Sigma Aldrich Pvt. Ltd), HCl (37% AR) 
(Sigma Aldrich Pvt. Ltd), and high purity hydrogen peroxide (35.5%) (Sigma Aldrich Pvt. Ltd), Laboratory 
glassware was kept overnight in 10% (v/v) nitric acid. Before use, the glassware were rinsed with de-ionized water 
and dried in a dust free environment. 
03. Results 
Percentage abnormal skin manifestations (Fig 02) observed in the sample of CKDu patients and with individuals of 
the control group are presented in Table 01. More than half the patients (54.4%) have shown hyper pigmentation in 
palms and 49% in soles although prevalence of keratosis was relatively low among them. Furthermore, nearly 10 to 
25% of the individuals of control group too manifested the manifestations. Some individuals in the control group 
also showed other symptoms manifested in CKDu patients, nevertheless in a lesser degree (Table 2).  
Burning of the eyes, parasthesia and epigastric pain are not common symptoms in patients with chronic kidney 
disease unless a patient is at the final stages of renal failure or the patient is affected by the adverse effects of a drug. 
Hence these three symptoms can be identifed to a certain extent, as characteristic to CKDu patients. Even to a lesser 
extent, these symptoms were observed among individuals of the control group too. 
Table 1: Percentage dermal manifestation observed in the case and control groups 
 
. 
 
 
 
 
 
 
 
Dermal manifestation Number of patients 
(n=125) 
% Number of 
controls (n=180) 
% 
Hyper pigmentation of palms 68 54.4 34 18.8 
Hyper pigmentation of soles  49 39.2 26 14.4 
Keratosis of palms  29 23.2 19 10.5 
Keratosis of soles  22 17.6 15 08.3 
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Table 2: Other clinical symptoms manifested by CKDu patients and individuals in control group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 02- Abnormal skin manifestations of CKDu patients encountered in the study area 
This substantiates the observations made on incidence of keratosis and hyper-pigmentation among the population in 
this study area. Since it is evident that with the exception of dermal manifestations, other clinical features of chronic 
arsenic poisoning can occur under some other medical conditions too, history of exposure to arsenic, arsenic content 
in hair and urine have to be considered along with clinical features to arrive at a conclusive judgment on chronic 
arsenic poisoning. Previous studies have shown urinary excretion of arsenic and its concentration in hair and nail are 
most important biomarkers of internal exposure.(Hindmash 1998). In general, blood concentrations of arsenic are too 
low and transient; hence it is not considered a biomarker for chronic arsenic poisoning (Muzumder 2000). Total 
arsenic amount in urine has been in use as an indicator of recent arsenic exposure because kidney is the main route of 
the excretion of many arsenic species (Buchet et al.1981). Half life of inorganic arsenic in humans is about 4 days. In 
European population, average urinary arsenic concentration is less than 10 µg/L (Apeal and Stoeppler 1983;,Trepka 
et al.;1996 and Kavanagh et al.,1998). Urinary arsenic levels detected among the subjects of the present study are 
presented in Table 3 while table 4 shows calculation of Odds ratios. 
Toxic excretory level for arsenic in urine for south Asian population is 35µg/L. (Muzumder 2000). Among the 
patients, 68% and 28% among the controls had urine arsenic levels above 21 µg/g creatinine. Urine arsenic levels of 
21 µg/g creatinine is considered as the threshold for commencing early renal changes which can potentially lead to 
chronic kidney disease. 
Other clinical symptoms observed among the subjects 
of the study 
CKDu 
patients (%) 
Controls (%) 
Generalized body weakness 95 35 
Headache 91 44 
Burning of eyes 84 12 
Nausia 76 18 
Mild to moderate hepatomegaly and spleenomegaly 25 04 
Epigastric pain 63 16 
Paresthesia 51 12 
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Table 3: Urinary arsenic contents of CKDu patients and individuals of the control group 
 
Urinary arsenic 
Concentration (µg/L) 
CKDu patients (%) 
(n=125) 
Controls (%) 
(n=180) 
0-10 4.0 10.0 
10-20 4.8 13.3 
20-30 6.4 26.6 
30-40 12.0 21.2 
40-50 32.0 14.4 
50-60 25.6 10.0 
>60 15.2 4.5 
 
Table 4: Urinary arsenic contents and Odds ratios 
 
 
 
 
 
 
 
 
 
 
Arsenic is known to have higher affinity to keratin. Hence comparatively high concentration of arsenic has been 
observed in high keratin containing tissues such as hair and nails (Table 5). Concentration of arsenic in hair of 
humans with no known exposure to arsenic,generally ranges 0.02-0.2 mg/kg (Valentine et al.1979;,Narang et 
al.1987;Wang et al.1994 and Kurttio et al.1998). Hair samples of CKDu patients contained high amount of arsenic 
compared to that of individuals in the control. It further substantiates the chronic arsenic poisoning of CKDu patients 
in the study area. 
 
Table 5: Arsenic content in hair samples of CKDu patients and individuals of the control group 
 
      Hair samples  Arsenic -mg/kg  
Mean-Normal (Muzumdar 2000)  0.46  
Control group  0.22±0.01 to 4.58±0.98  
CKDu patients  1.27±0.22  to  7.03±1.06  
 
04.Discussion and conclusion  
Dermatological features supported by toxic levels of arsenic in urine and hair are confirmatory for chronic arsenic 
poisoning. (Muzumder 2000) There is a wide variation in the incidence of chronic arsenic poisoning in an affected 
population. In a study done at west Bengal has shown that even not all members of an affected family show clinical 
symptoms.(Muzumder 2000) Dermal manifestation such as hyper pigmentation and hyperkeratosis are diagnostic of 
Urinary Arsenic  Conc. CKD patients 
n = 125 
Controls 
n = 108 
Odds Ratios 
30-40 (Reference) 15 38 1.00 
0-10 5 18 0.90  (95% CI = 0.24 - 3.42) 
10-20 6 24 1.50  (95% CI = 0.47 - 4.82) 
20-30 8 48 0.63  (95% CI = 0.22 - 1.86) 
40-50 40 26 0.16  (95% CI = 0.06 - 0.45) 
50-60 32 18 0.14  (95% CI = 0.05 - 0.41) 
60+ 19 8 0.11  (95% CI = 0.03 - 0.36) 
30 + (Reference) 106 90 1.00 
0-29 19 90 5.58  (95% CI = 3.16 - 9.86) 
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chronic arsenic poisoning. However dermal manifestations depend on age, gender, ethnicity, skin colour and type of 
arsenic that is ingested.  
Findings of the present study reveal that 48% of the CKDu patients and 17.4% of the subjects in the control group 
have fulfilled the requirements to be diagnosed CAT. Percentage CKDu patients who fulfill the requirements for 
CAT were greater than that among the control group. Calculation of ODDS ratios shows that the individuals who 
excrete more than 35µg/L of arsenic in urine are 5.58 times more likely o develop CKDu. Observable CAT 
symptoms among individuals of the control group indicate that being inhabitants of the same area and having to 
consume contaminated water and food majority of the population has already bio-accumulated arsenic, nevertheless 
to a lesser extent than those who have been diagnosed as CKDu patients. This also implies that these individuals are 
of high risk in acquiring CKDu in near future. 
CKDu represents an immerging new type of nephropathy, caused potentially by chronic arsenic poisoning with the 
contribution of heavy metals, pesticide residues, heat stress and chronic repeated dehydration (Personal 
communication Daniel Brooks, Boston University, USA 2012), poor quality of drinking water and genetic variations 
(Specially AS3MT gene).(Fig 03)  
It is appropriate therefore to subject the deceased patients to complete medico-legal autopsy including histo-
pathological and toxicological investigations. Ideally, as this is not a deliberate self poisoning clinical subjects are 
supposed to get a medico-legal referral. But it has not taken place in the clinical setup yet. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 03-Possible mechanism to explain the occurrence of CKDu in Sri Lanka 
Continuation of this research to explore the possible contamination of arsenic among the farmers with CKDu 
suggested that the arsenic is not present naturally in the soils of the study area and thus investigations have been 
As-Arsenic 
Cd-Cadmium 
Hg-Mercury 
U-Uranium 
NSAIDs-Non steroidal 
anti inflammatory drugs 
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carried out to test the agrochemicals, namely, pesticides, herbicides and inorganic fertilizer for arsenic. The 
agrochemicals were tested in an accredited laboratory in Malaysia for arsenic and the results have confirmed the 
presence of arsenic in agrochemicals. (Jayasumana et al.2011) Since no reported work is available as to the presence 
of arsenic in the bedrocks below Sri Lankan land mass, pesticides and fertilizers that are excessively used in paddy 
farming should be attributed as the most likely sources of arsenic in CKDu patients in the study area. 
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